Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non–Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases

IMPORTANCE: Purpuric skin lesions have only rarely been reported in patients receiving epidermal growth factor receptor inhibitors. However, their clinical and histopathologic presentations have varied considerably. OBJECTIVE: To characterize purpuric skin eruptions caused by epidermal growth factor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Dermatol
Main Authors: Cho, Yung-Tsu, Chen, Kai-Lung, Sheen, Yi-Shuan, Yang, Che-Wen, Liau, Jau-Yu, Cheng, Yu-Pin, Chu, Chia-Yu
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817454/
https://ncbi.nlm.nih.gov/pubmed/28538945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.0903
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados